Frédéric Di Fiore
About
Frédéric Di Fiore is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology.
According to data from OpenAlex, Frédéric Di Fiore has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 16 papers in Oncology. Recurrent topics in Frédéric Di Fiore's work include Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (15 papers) and Cancer Genomics and Diagnostics (14 papers). Frédéric Di Fiore is often cited by papers focused on Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (15 papers) and Cancer Genomics and Diagnostics (14 papers). Frédéric Di Fiore collaborates with scholars based in France, Luxembourg and United States. Frédéric Di Fiore's co-authors include Pierre Michel, B Paillot, David Sefrioui, Stéphane Lecleire, H. Hamidou, Philippe Ducrotté, Éric Lerebours, David Tougeron, Olivier Rigal and Thierry Frébourg and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.
In The Last Decade
Frédéric Di Fiore
45 papers receiving 1.2k citations
Peers
Frédéric Di Fiore
Felice N. van Erning Netherlands
Antonia Strippoli Italy
Toshiki Masuishi Japan
Luigi Sofo Italy
David Liska United States
Chiaki Kagebayashi Japan
R. Adam France
M.A. Paul Netherlands
Daniel Swinson United Kingdom
Citations per year, relative to Frédéric Di Fiore Frédéric Di Fiore (= 1×)
peers
Felice N. van Erning
Countries citing papers authored by Frédéric Di Fiore
Since
Specialization
Citations
This map shows the geographic impact of Frédéric Di Fiore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Di Fiore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Di Fiore more than expected).
Fields of papers citing papers by Frédéric Di Fiore
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Frédéric Di Fiore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Di Fiore. The network helps show where Frédéric Di Fiore may publish in the future.
Co-authorship network of co-authors of Frédéric Di Fiore
This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Di Fiore. A scholar is included among the top collaborators of Frédéric Di Fiore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Di Fiore. Frédéric Di Fiore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gillibert, André, et al.. (2025). Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma. Clinics and Research in Hepatology and Gastroenterology. 49(5). 102583–102583.
2.
Elie, Caroline, Karine Bouhier‐Leporrier, Aurélie Parzy, et al.. (2025). ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer. British Journal of Cancer. 132(9). 814–821.
3.
Perdrix, Anne, Anne Rovelet‐Lecrux, Nasrin Sarafan‐Vasseur, et al.. (2024). Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer. Frontiers in Oncology. 14. 1382008–1382008.
4.
Fiore, Frédéric Di, Nancy Larochelle, Danielle Arbour, et al.. (2024). Reversal of cognitive deficits in FUSR521G amyotrophic lateral sclerosis mice by arimoclomol and a class I histone deacetylase inhibitor independent of heat shock protein induction. Neurotherapeutics. 21(5). e00388–e00388.
5.
Michel, Pierre, et al.. (2022). Colorectal cancer chemoprevention: is aspirin still in the game?. Cancer Biology & Therapy. 23(1). 446–461.
6.
Vermeulin, Thomas, Emmanuel Huet, Frédéric Di Fiore, et al.. (2019). Patients’ perception and attitude to totally implantable venous access for urologic or digestive cancer: A cross-sectional study. Bulletin du Cancer. 106(11). 959–968.
7.
Bastit, Vianney, Nicolas Bon‐Mardion, Jean‐Michel Picquenot, et al.. (2018). Benefit of cetuximab addition to a platinum–fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers. European Archives of Oto-Rhino-Laryngology. 276(2). 541–550.
8.
Garlan, Fanny, Pierre Laurent‐Puig, David Sefrioui, et al.. (2017). Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study). Clinical Cancer Research. 23(18). 5416–5425.
9.
Lange, Marie, Hélène Castel, Natacha Heutte, et al.. (2017). Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. BMC Cancer. 17(1). 110–110.
10.
Nouhaud, François‐Xavier, et al.. (2015). Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma. Anti-Cancer Drugs. 26(8). 866–871.
11.
Vincent, Julie, C. Mariette, Denis Pezet, et al.. (2015). Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer. 51(13). 1683–1693.
12.
Lecleire, Stéphane, Alice Gangloff, Olivier Rigal, et al.. (2014). Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer. Digestive and Liver Disease. 46(3). 270–275.
13.
Lemarignier, Charles, Frédéric Di Fiore, Sébastien Hapdey, et al.. (2014). Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 41(11). 2008–2016.
14.
Michel, Pierre, Jean-François Ménard, Caroline Rousseau, et al.. (2013). The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). European Journal of Nuclear Medicine and Molecular Imaging. 40(9). 1345–1355.
15.
Tougeron, David, H. Hamidou, Michel Scotté, et al.. (2010). Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 10(1). 510–510.
16.
Tougeron, David, Émilie Fauquembergue, Alexandre Rouquette, et al.. (2009). Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Modern Pathology. 22(9). 1186–1195.
17.
Lecleire, Stéphane, Frédéric Di Fiore, Michel Antonietti, et al.. (2008). Nonoperable Patients With Superficial Esophageal Cancer Treated by Photodynamic Therapy After Chemoradiotherapy Have More Severe Complications Than Patients Treated in Primary Intent. The American Journal of Gastroenterology. 103(9). 2215–2219.
18.
Tougeron, David, B. Lefébure, Guillaume Savoye, et al.. (2008). Small-bowel adenocarcinoma in patient with Crohn's disease: Report of a series of three cases. Scandinavian Journal of Gastroenterology. 43(11). 1397–1400.
19.
Fiore, Frédéric Di, Stéphane Lecleire, Daniela Pop, et al.. (2007). Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer. The American Journal of Gastroenterology. 102(11). 2557–2563.
20.
Soussan, E Ben, Michel Antonietti, Stéphane Lecleire, et al.. (2005). Palliative esophageal stent placement using endoscopic guidance without fluoroscopy. Gastroentérologie Clinique et Biologique. 29(8-9). 785–788.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Felice N. van Erning Breakdown of academic impact, for papers by Antonia Strippoli Breakdown of academic impact, for papers by Toshiki Masuishi Breakdown of academic impact, for papers by Luigi Sofo Breakdown of academic impact, for papers by David Liska Breakdown of academic impact, for papers by Chiaki Kagebayashi Breakdown of academic impact, for papers by R. Adam Breakdown of academic impact, for papers by M.A. Paul Breakdown of academic impact, for papers by Encarnación González‐Flores Breakdown of academic impact, for papers by Daniel Swinson